AVXL - Anavex Life Sciences Corporation
IEX Last Trade
6.02
0.050 0.831%
Share volume: 549,970
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.97
0.05
0.84%
Summary score
25%
Profitability
25%
Dept financing
5%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-29.93%
Return on assets
-25.8%
Return on sales
0%
Return on invested capital
139.8%
Total debt ratio
17.14%
Debt ratio change over timeo
-0.86%
Current Ratio
7.12%
Quick Ratio
0%
Cash Position Ratio
6.77%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-25%
Return on assets
-25.06%
Return on sales
0%
Return on invested capital
101.87%
Total debt ratio
19.83%
Debt ratio change over timeo
-0.83%
Current Ratio
5.08%
Quick Ratio
0%
Cash Position Ratio
4.42%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-26.28%
Return on assets
-25.63%
Return on sales
0%
Return on invested capital
93.67%
Total debt ratio
21.97%
Debt ratio change over time
-0.81%
Current Ratio
4.55%
Quick Ratio
0%
Cash Position Ratio
3.97%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-124.38%
Return on assets
-120.82%
Return on sales
0%
Return on invested capital
15.37%
Total debt ratio
-86.48%
Debt ratio change over time
-0.86%
Current Ratio
4.8%
Quick Ratio
0%
Cash Position Ratio
4.56%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AVXL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -29.93% | -3.05% | 11.55% | 6.27% |
| Return on assets | -25.8% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 139.8% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 61% |
| Total debt ratio | 17.14% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.86% | 6.09% | 6.03% | 1.53% |
| Dept financing | 4% | 50% | 43% | 14% |
| Current Ratio | 5.08% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.42% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 18% | 40% | 40% |
| Short-term ratios | AVXL | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -25% | -25.62% | 17.94% | 7.14% |
| Return on assets | -25.06% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 101.87% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 40% | 71% | 62% |
| Total debt ratio | 19.83% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.83% | -23.44% | 9.66% | 0.6% |
| Dept financing | 5% | 25% | 45% | 8% |
| Current Ratio | 5.08% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 4.42% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 36% | 29% | 51% |